The VDGH represents manufacturers of in vitro diagnostic devices in Germany and, in addition, manufacturers of CGM systems. CGM systems are not in vitro diagnostic medical devices, but rather medical devices as defined by Regulation (EU) 2017/745. Under social security law, they are classified as medical aids pursuant to Section 33 of Book V of the Social Code (SGB V) and are listed in Product Group 21 of the Medical Aids Directory. Unlike in many other product areas, manufacturers here predominantly provide care to insured individuals themselves as service providers based on contracts under Section 127 of SGB V. The VDGH’s member companies are therefore directly affected by the regulations governing contract law, billing, and copayments.
CGM also represents a typical form of long-term care. Insured individuals with diabetes mellitus receive sensors at short, regular intervals over many years. Every administrative requirement that applies per delivery or per prescription is multiplied in this area of care. The VDGH evaluates the proposed regulations against this standard.
